Frequently Asked Questions: Clinical Operations in China for International Biopharmas
Frequently Asked Questions: Clinical Operations in China for International Biopharmas
Regulatory Framework & Approval ProcessQ: What is the regulatory pathway for international biotechs to conduct clinical trials in China?A: International biotechs must submit an Investigational New Drug (IND) application to China's National Medical Products Administration (NMPA) through the ...
Why Global Biotechs Are Turning to China for Clinical Trials: The Speed, Quality, and Cost Advantage
Why Global Biotechs Are Turning to China for Clinical Trials: The Speed, Quality, and Cost Advantage
In today's competitive pharmaceutical landscape, the ability to conduct efficient, high-quality clinical trials is essential for bringing innovative therapies to market. As international pharmaceutical companies seek strategic advantages in their development programs, China has emerged as a global l...